Appears On
Episode Appearances
Moonshots with Peter Diamandis · Apr 28, 2026
David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251
“Namesake of Hayflick limit; Sinclair discusses telomere research building on his foundational work in cellular division limits”
GLP-1 drug side effects and safety monitoringAI-driven drug design and molecular screeningCellular reprogramming (OSK therapy)
View Analysis